Research Article
Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study
Table 2
Dyslipidemia prevalence in the participant based on laboratory results and the adult treatment panel (ATP III criteria).
| Fasting lipoprotein levels based on ATP III | Level (mg/dL) | Frequency () | Valid (%) | Cumulative (%) |
| TC | Desirable | <200 | 97 | 69.3 | 69.3 | Borderline high | 200–239 | 38 | 27.1 | 96.4 | High | ≥240 | 5 | 3.6 | 100 |
| LDL | Optimal | <100 | 34 | 24.3 | 24.3 | Above optimal | 100–129 | 51 | 36.4 | 60.7 | Borderline high | 130–159 | 43 | 30.7 | 91.4 | High | 160–189 | 10 | 7.1 | 98.6 | Very high | ≥190 | 2 | 1.4 | 100 |
| HDL | Low | <40 | 83 | 59.3 | 59.3 | Normal | 40–59 | 53 | 37.9 | 97.1 | High | ≥60 | 4 | 2.9 | 100 |
| TG | Normal | <150 | 77 | 55 | 55 | Borderline high | 150–199 | 35 | 25 | 80 | High | 200–490 | 27 | 19.3 | 99.3 | Very high | ≥500 | 1 | 0.7 | 100 |
|
|